Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -32.91% is 80% above its 5-year average of -165.59%, near the high end of its 5-year range (-448.61%–-32.91%).
64.73% above its 12-month average of -93.30%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -102.77%.
EBITDA MARGIN
-32.91%
EBITDA MARGIN AVG TTM
-93.30%
EBITDA MARGIN AVG 3Y
-119.79%
EBITDA MARGIN AVG 5Y
-165.59%
EBITDA MARGIN AVG 10Y
-124.79%
EBITDA MARGIN AVG 15Y
-146.55%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+64.73%
CURRENT VS 3Y AVG
+72.53%
CURRENT VS 5Y AVG
+80.13%
CURRENT VS 10Y AVG
+73.63%
CURRENT VS 15Y AVG
+77.54%
CURRENT VS 20Y AVG
N/A
Pacific Biosciences of California, Inc.
Market Cap
$838.62M
EBITDA Margin
-32.91%
TTM Avg
-93.30%
3Y Avg
-119.79%
5Y Avg
-165.59%
Market Cap
$838.16M
EBITDA Margin
-68.63%
TTM Avg
-68.17%
3Y Avg
-9114.49%
5Y Avg
-9114.49%
Market Cap
$833.81M
EBITDA Margin
-37.08%
TTM Avg
-66.80%
3Y Avg
-66.80%
5Y Avg
-66.80%
Market Cap
$828.48M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$852.35M
EBITDA Margin
-170.39%
TTM Avg
-102.27%
3Y Avg
-63.10%
5Y Avg
-63.10%
Market Cap
$853.13M
EBITDA Margin
43.46%
TTM Avg
29.10%
3Y Avg
-0.91%
5Y Avg
-6.21%
Market Cap
$855.38M
EBITDA Margin
-1761.78%
TTM Avg
-1761.78%
3Y Avg
-1761.78%
5Y Avg
-1761.78%
Market Cap
$857.16M
EBITDA Margin
-17.48%
TTM Avg
-35.83%
3Y Avg
-4.31%
5Y Avg
17.66%
Market Cap
$817.67M
EBITDA Margin
-9.31%
TTM Avg
-8.54%
3Y Avg
-46.73%
5Y Avg
-472.39%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacific Biosciences of California, Inc. (PACB) | $838.62M | -32.91% | -93.30% | -119.79% | -165.59% |
| Beta Bionics, Inc. (BBNX)vs › | $838.16M | -68.63% | -68.17% | -9114.49% | -9114.49% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $833.81M | -37.08% | -66.80% | -66.80% | -66.80% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $828.48M | N/A | N/A | N/A | N/A |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | -170.39% | -102.27% | -63.10% | -63.10% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 43.46% | 29.10% | -0.91% | -6.21% |
| Alumis Inc. (ALMS)vs › | $855.38M | -1761.78% | -1761.78% | -1761.78% | -1761.78% |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | -17.48% | -35.83% | -4.31% | 17.66% |
| Ardelyx, Inc. (ARDX)vs › | $817.67M | -9.31% | -8.54% | -46.73% | -472.39% |
| Jade Biosciences, Inc. (JBIO)vs › | $816.13M | N/A | N/A | N/A | N/A |
Gross Margin
36.0%
EBITDA Margin
-32.9%
Operating Margin
-348.5%
Net Margin
-82.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -102.77% |
| 2026-03-31 | -91.06% |
| 2025-12-31 | -81.86% |
| 2025-09-30 | -89.52% |
| 2025-06-30 | -101.27% |
| 2025-03-31 | -151.15% |
| 2024-12-31 | -362.22% |
| 2024-09-30 | -120.04% |
| 2024-06-30 | -448.61% |
| 2024-03-31 | -178.69% |
| 2023-12-31 | -119.42% |
| 2023-09-30 | -138.33% |
| 2023-06-30 | -143.59% |
| 2023-03-31 | -222.97% |
| 2022-12-31 | -301.76% |
| 2022-09-30 | -217.59% |
| 2022-06-30 | -179.61% |
| 2022-03-31 | -221.06% |
| 2021-12-31 | -168.22% |
| 2021-09-30 | -205.71% |
| 2021-06-30 | -114.93% |
| 2021-03-31 | -107.99% |
| 2020-12-31 | -79.70% |
| 2020-09-30 | -114.55% |
| 2020-06-30 | -124.45% |
| 2020-03-31 | -194.53% |
| 2019-12-31 | -55.16% |
| 2019-09-30 | -116.60% |
| 2019-06-30 | -89.17% |
| 2019-03-31 | -168.55% |
| 2018-12-31 | -147.72% |
| 2018-09-30 | -125.80% |
| 2018-06-30 | -92.39% |
| 2018-03-31 | -114.38% |
| 2017-12-31 | -75.07% |
| 2017-09-30 | -83.99% |
| 2017-06-30 | -111.58% |
| 2017-03-31 | -82.08% |
| 2016-12-31 | -65.40% |
| 2016-09-30 | -62.65% |
| 2016-06-30 | -82.40% |
| 2016-03-31 | -92.63% |
| 2015-12-31 | -0.22% |
| 2015-09-30 | 24.88% |
| 2015-06-30 | -41.78% |
| 2015-03-31 | -104.39% |
| 2014-12-31 | -100.47% |
| 2014-09-30 | -35.95% |
| 2014-06-30 | -150.65% |
| 2014-03-31 | -146.23% |
| 2013-12-31 | -170.72% |
| 2013-09-30 | -250.56% |
| 2013-06-30 | -307.42% |
| 2013-03-31 | -342.67% |
| 2012-12-31 | -341.71% |
| 2012-09-30 | -752.56% |
| 2012-06-30 | -285.71% |
| 2012-03-31 | -257.83% |
| 2011-12-31 | -170.22% |
| 2011-09-30 | -266.15% |
| 2011-06-30 | -200.15% |
| 2011-03-31 | -12407.04% |
| 2010-12-31 | -12547.14% |
| 2010-09-30 | -17842.27% |
| 2010-06-30 | -5002.54% |
| 2010-03-31 | -5362.02% |
| 2009-12-31 | -19425.93% |
